Clinical Practice Evolvement for Post-Operative Prostate Cancer Radiotherapy-Part 2: Feasibility of Margin Reduction for Fractionated Radiation Treatment with Advanced Image Guidance.
PTV margins
advanced image guidance
iCBCT
post prostatectomy radiotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
21 Dec 2022
21 Dec 2022
Historique:
received:
30
10
2022
revised:
08
12
2022
accepted:
16
12
2022
entrez:
8
1
2023
pubmed:
9
1
2023
medline:
9
1
2023
Statut:
epublish
Résumé
Purpose: Planning target volume (PTV) expansion for post-prostatectomy radiotherapy is typically ≥5 mm. Recent clinical trials have proved the feasibility of a reduced margin of 2−3 mm for treatments on MRI-linac. We aim to study the minimum PTV margin needed using iterative cone-beam CT (iCBCT) as image guidance on conventional linacs. Materials/Methods: Fourteen patients who received post-prostatectomy irradiation (8 with an endorectal balloon and 6 without a balloon) were included in this study. Treatment was delivered with volumetric modulated radiation therapy (VMAT). Fractional dose delivery was evaluated in 165 treatment fractions. The bladder, rectal wall, femoral heads, and prostate bed clinical tumor volume (CTV) were contoured and verified on daily iCBCT. PTV margins (0 mm, 2 mm, and 4 mm) were evaluated on daily iCBCT. CTV coverage and OAR dose parameters were assessed with each PTV margin. Results: CTV D100% was underdosed with a 0 mm margin in 32% of fractions in comparison with 2 mm (6%) and 4 mm (6%) PTV margin (p ≤ 0.001). CTV D95% > 95% was met in 93−94% fractions for all PTV expansions. CTV D95% > 95% was achieved in more patients with an endorectal balloon than those without: 0 mm—90/91 (99%) vs. 63/74 (85%); 2 mm—90/91 (99%) vs. 65/75 (87%); 4 mm—90/90 (100%) vs. 63/73 (86%). There was no difference in absolute median change in CTV D95% (0.32%) for 0-, 2-, and 4 mm margins. The maximum dose remained under 108% for 100% (0 mm), 97% (2 mm), and 98% (4 mm) of images. Rectal wall maximum dose remained under 108% for 100% (0 mm), 100% (2 mm), and 98% (4 mm) of images. Conclusions: With high-quality iCBCT image guidance, PTV margin accounting for inter-fractional uncertainties can be safely reduced for post-prostatectomy radiotherapy. For fractionated radiotherapy, an isotropic expansion of 2 mm and 4 mm may be considered for margin expansion with and without the endorectal balloon. Future application for margin reduction needs to be further evaluated and considered with the advent of shorter post-prostatectomy radiation courses.
Identifiants
pubmed: 36612040
pii: cancers15010040
doi: 10.3390/cancers15010040
pmc: PMC9817842
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):361-8
pubmed: 19394158
Cancers (Basel). 2021 Jun 04;13(11):
pubmed: 34199881
Med Phys. 2022 Dec;49(12):7715-7732
pubmed: 36031929
Radiother Oncol. 2020 Jul;148:44-50
pubmed: 32311600
J Urol. 2019 Sep;202(3):533-538
pubmed: 31042111
Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1090-9
pubmed: 17967303
Adv Radiat Oncol. 2019 Jan 10;4(2):390-400
pubmed: 31011685
Adv Radiat Oncol. 2022 Dec 10;8(2):101143
pubmed: 36845611
Int J Radiat Oncol Biol Phys. 2023 Jan 1;115(1):142-152
pubmed: 36007724
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1038-44
pubmed: 23021439
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):402-7
pubmed: 22381905
Am J Clin Oncol. 2010 Feb;33(1):11-6
pubmed: 19730351
J Med Imaging Radiat Oncol. 2009 Apr;53(2):212-20
pubmed: 19527370
Cancer Radiother. 2016 Oct;20(6-7):629-39
pubmed: 27614515
Radiother Oncol. 2007 Aug;84(2):121-7
pubmed: 17706307
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1302-9
pubmed: 21035952
J Med Radiat Sci. 2019 Dec;66(4):259-268
pubmed: 31680490
Radiat Oncol. 2015 Jul 26;10:151
pubmed: 26209446
Radiat Oncol. 2021 Jan 22;16(1):20
pubmed: 33482863
Cancers (Basel). 2022 Dec 20;15(1):
pubmed: 36612013
Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1407-22
pubmed: 11955756
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1121-35
pubmed: 10863086
Radiother Oncol. 2014 Feb;110(2):235-9
pubmed: 24485766
Radiother Oncol. 2008 Jul;88(1):10-9
pubmed: 18514340